STROKE: DRUG (THROMBOLYTIC) THERAPY
Tracking # 20-411736
$99999.00
Course overview
The primary goal in the treatment of ischemic stroke is prompt revascularization. Thrombolytic therapy is based on the premise that cerebral ischemia and its consequences can be limited by dissolving the occlusion as quickly as possible. This continuing education module is designed to give the reader/learner an increased understanding of drug (thrombolytic) therapy in stroke treatment and complications of thrombolytic therapy, and to aid in caring for the patient receiving this treatment. Readers may explore any or all of the topics. One contact hour of continuing education credit is available for those who successfully complete the post-test and evaluation form.
Subject areas
This course counts toward the state boards and subject areas below.